#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Xatral (Alfuzosin) 2.5 mg in the Treatment of BPH


Authors: J. Novák
Authors‘ workplace: Urologická klinika VFN, Praha, přednosta prof. MUDr. J. Dvořáček, DrSc
Published in: Prakt. Lék. 2001; (7): 396-399
Category:

Overview

772 patients from 68 urological departments took part in the study with alfuzosin 2.5 mg threetimes daily for treatment symptoms of BPH. The study lasted 3 months. The results andpatients’ quality of life were compared with the IPSS score and AUA symptom score. Adverseevents were minimal. The number of orthostatic hypotension was relatively low (1.8%). Thebenefit of the treatment for the patients with BPH treated with alfuzosin 2.5 mg t.i.d. wasrelatively good with a minimal number of adverse events.

Key words:
NPH - study - alfuzosin.

Full text is not available online.
If interested in a scan of this journal, contact NTO ČLS JEP.

Labels
General practitioner for children and adolescents General practitioner for adults
Topics Journals
Login
Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.

Login

Don‘t have an account?  Create new account

#ADS_BOTTOM_SCRIPTS#